💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Hedge fund manager used terminally ill patients for profit: SEC

Published 08/15/2016, 06:38 PM
Hedge fund manager used terminally ill patients for profit: SEC
C
-

By Suzanne Barlyn

(Reuters) - A hedge-fund manager paid terminally ill patients to use their names in a bond-buying scheme that generated $9.5 million in profits, a U.S. securities regulator said on Monday.

Donald "Jay" Lathen, Jr., who manages Eden Arc Capital Management LLC, was charged with fraud after putting the patients' names on joint brokerage accounts, along with his own, so he could buy bonds for his fund and profit by selling them back to issuers when the patients died, according to a U.S. Securities and Exchange Commission complaint.

Lathen opened 60 such accounts since May 2011, but none listed his fund as the owner or Lathen as an agent. The fund could not legally be a joint owner with survivorship rights because it is a corporate entity, the SEC said.

"We have no doubt that Mr. Lathen's investment strategy is entirely legitimate and violates no law, and we intend to vigorously defend him against the SEC's meritless charges," said Lathen's New York-based lawyer, Harlan Protass, in a statement. "Mr. Lathen looks forward to clearing his name."

Lathen will be able to refute the SEC's allegations in an administrative proceeding.

According to the SEC's complaint, the 48-year-old hedge fund manager used contacts at nursing homes and hospices to help him identify patients who had less than six months to live. He promised the patients $10,000 in exchange for becoming a joint account owner.

Lathen promoted an "end of life financial assistance program" to the terminally ill through EndCare, a company he founded in 2009, to induce them to sign on to the joint accounts, the SEC said.

Using those accounts, Eden Arc bought medium and long-term bonds, as well as certificates of deposits, that include so-called "death puts" that allow a deceased person's beneficiaries to sell the bonds back to the issuers at full par value. The strategy earned money because Eden Arc initially bought the bonds in secondary markets for less than par.

As patients died, Lathen sent letters to issuers saying he was the joint owner, the SEC said. The conduct was "reckless" the SEC said, because Lathen knew the statements were false.

The fund also ran afoul of SEC rules for the proper holding of funds, known as "custody," because Lathen listed his own name on the brokerage accounts, the SEC said.

Lathen launched Eden Arc Capital Partners, LP in 2011. From May 2011 through September 2015, the fund claimed total returns of 74.7 percent. It managed about $52 million at its peak, but that declined to $31 million in January, the SEC said.

Prior to Eden, Lathen was an energy investment banker at Citigroup Inc (NYSE:C) and Lehman Brothers.

(Corrects paragraph 2 to Management instead of Manager.)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.